A series of chalcones and their derivatives have been synthesized and
identified as novel potential antimalarials using both molecular model
ing and in vitro testing against the intact parasite. A large number o
f chalcones and their derivatives were prepared using one-step Claisen
-Schmidt condensations of aldehydes with methyl ketones. These condens
ates were screened in vitro against both chloroquine-sensitive and chl
oroquine-resistant strains of Plasmodium falciparum and shown to be ac
tive at concentrations in the nanomolar range. The most active chalcon
e derivative, ,5-dichlorophenyl)-3-(4-quinolinyl)-2-propen-1-one (7),
had an IC50 value of 200 nM against both a chloroquine-resistant strai
n (W2) and a chloroquine-sensitive strain (D6). The resistance indexes
for all compounds were substantially lower than for chloroquine, sugg
esting that this series will be active against chloroquine-resistant m
alaria. Structure-activity relationships (SAR) of the chalcones in the
context of a homology-based model structure of the malaria trophozoit
e cysteine protease, the most likely target enzyme, are presented.